| Ytd | 50.92% | |
| 1y | -34.62% |
| Open | 0.42 | Prev Close | 0.43 | Low | 0.41 | High | 0.42 | Mkt Cap | 36.44M |
| Vol | 17.98K | Avg Vol | 305.48K | EPS | -0.06 | P/E | -6.87 | Forward P/E | -21.75 |
| Beta | 1.05 | Short Ratio | 1.65 | Inst. Own | 5.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 0.37 | 200-d Avg | 0.34 | 1yr Est | 2.13 |
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments
NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-ye